Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

Market Cap	10.31B
Revenue (ttm)	612.17M +1,182.2%
Net Income	117.33M +584.5%
EPS	2.03 +315.0%
Shares Out	78.84M
PE Ratio	64.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	453,400
Average Volume	674,527
Open	122.99
Previous Close	121.68
Day's Range	122.41 - 127.40
52-Week Range	98.36 - 132.00
Beta	n/a
RSI	75.37
Earnings Date	Feb 14, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limit...

• Industry: Hospitals
• Founded: 2014
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GKSL

Financial Performance

In fiscal year 2025, NSE:GKSL's revenue was 402.42 million, an increase of 742.89% compared to the previous year's 47.74 million. Earnings were 94.13 million, an increase of 449.19%.